| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |